Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
06/2005
06/07/2005US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
06/07/2005US6903123 Antitussive agents, anxiolytic agents, analgesics for treating cough, anxiety and pain
06/07/2005US6903119 (2R)-N-(1-benzylpiperidin-4-yl)-3-cyclohexylmethylthio-2-((4R) -3-(pyridin-3-ylcarbonyl)thiazolidin-4-ylcarbonylamino)propana mide, calcium channel blocker, treatment of cerebral infarct, transient ischemic attack, spinal angiopathy
06/07/2005US6903118 Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903112 Nitrogen compounds such as 1-benzenesulfonyl-3-piperidin-3-yl -1H-indole, used as serotonin receptor antagonists, for prophylaxis of nervous system disorders
06/07/2005US6903104 Antitumor agents, anticarcinogenic agents, a 3-oxoacetamideindolyl compounds, for treating cancer, cytotoxic, and angiogensis inhibitors
06/07/2005US6903103 Linear cyclic ureas
06/07/2005US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2005US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/07/2005CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders
06/02/2005WO2005049610A1 Process for preparing thiazolidinediones
06/02/2005WO2005049604A2 Antithrombotic aromatic ethers
06/02/2005WO2005049594A1 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049593A2 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049581A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/02/2005WO2005049579A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
06/02/2005WO2005049577A1 1-amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5
06/02/2005WO2005049564A1 Amide derivatives and methods of their use
06/02/2005WO2005049559A2 Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3)
06/02/2005WO2005049532A2 A process for purification
06/02/2005WO2005049033A1 Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
06/02/2005WO2005049019A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
06/02/2005WO2005049018A1 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
06/02/2005WO2005048953A2 Amide derivatives as kinase modulators
06/02/2005WO2005048948A2 Urea derivatives as kinase modulators
06/02/2005WO2005048922A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
06/02/2005WO2005016879A3 Cyclic pyrazinoylguanidine sodium channel blockers
06/02/2005WO2005009950A3 Piperidine derivatives as melanocortin-4 receptor agonists
06/02/2005WO2004033440A8 Thiadiazoledioxides and thiadiazoleoxides as cxc- and cc-chemokine receptor ligands
06/02/2005US20050119489 Antidiabetic, anorexigenic, hypotensive, and anticholesterol agents that are synergistically combined with other active agents; obesity, premenstrual tension, hyperlipidemia, myocardial infarction and skin disorders
06/02/2005US20050119486 Diamine derivatives
06/02/2005US20050119484 Mitotic kinesin inhibitors
06/02/2005US20050119329 Tetronic and tetramic acids
06/02/2005US20050119327 1-benzyl-5-[(3-methylphenyl)amino]-3-phenyl-1H-indole-2-carboxylic acid; plasminogen activator inhibitor (PAI-1) inhibitor; fibrinolytic system disorder; atrial fibrillation, pulmonary and renal fibrosis, Alzheimer's disease; anticarcinogenic, antiischemic, anticoagulant, antidiabetic
06/02/2005US20050119320 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
06/02/2005US20050119317 such as (5RS)-3-(3-Fluoro-4-thiomorpholin-4-yl phenyl)-5-(1,2,3-triazol-1-ylmethyl)-4,5-dihydroisoxazole; antibiotics
06/02/2005US20050119311 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
06/02/2005US20050119293 For therapy of Alzheimer's disease
06/02/2005US20050119292 antibiotic; Gram-positive pathogens (Staphylococci, Enterococci, and Streptococci ), MRSA and MRCNS; resistance to vancomycin and E. faecium to both aminoglycosides and beta--lactams; gram negative strains H.influenzae, M.catarrhalis and chlamydia; improved activity against mono-amine oxidase (MAO)
06/02/2005US20050119277 Benzazole derivatives for the treatment of scleroderma
06/02/2005US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use
06/02/2005US20050119269 Heterocyclic compounds and methods of making and using thereof
06/02/2005US20050119268 Treatment of CRTH2-mediated diseases and conditions
06/02/2005US20050119257 Cyclic sulfone containing retroviral protease inhibitors
06/02/2005US20050119256 Aromatic amino acid derivates and medicinal compositions
06/02/2005US20050119252 Ligands of melanocortin receptors and compositions and methods related thereto
06/02/2005US20050119231 Quinolone antibiotics such as 3-Amino-1-cyclopropyl-6-fluoro-7-(3-hydroxymethyl-pyrrolidin-1-yl)-8-methoxy-1H-quinazoline-2,4-dione, used for treating gramnegative or grampositive bacterial infection in mammals
06/02/2005US20050119128 Substituted 4-hetaryl-pyrazolines as pest control agents
06/02/2005DE10335545A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis
06/02/2005CA2545719A1 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
06/02/2005CA2545711A1 Urea derivatives as kinase modulators
06/02/2005CA2545261A1 Piperidine-substituted indoles- or heteroderivatives thereof
06/02/2005CA2545193A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/01/2005EP1535915A1 Furan or thiophene derivative and medicinal use thereof
06/01/2005EP1535913A1 Novel quaternary ammonium compounds
06/01/2005EP1535910A1 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1535906A1 Nitrogen-containing compounds
06/01/2005EP1535630A1 Preventive for the onset of diabetes
06/01/2005EP1535616A1 Remedy for integration dysfunction syndrome
06/01/2005EP1534706A1 Furanthiazole derivatives as heparanase inhibitors
06/01/2005EP1534703A2 Antagonists of melanin concentrating hormone receptor
06/01/2005EP1534701A1 Substituted heterocyclylpyrimidines
06/01/2005EP1534700A1 Novel thiophene derivatives, preparation method thereof and pharmaceutical compositions containing same
06/01/2005EP1534696A1 Therapeutic compounds for treating dyslipidemic conditions
06/01/2005EP1534695A2 Tyrosine kinase inhibitors
06/01/2005EP1534685A1 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors
06/01/2005EP1534681A1 Substituted quinoline ccr5 receptor antagonists
06/01/2005EP1534680A1 Prenylation inhibitors and methods of their synthesis and use
06/01/2005EP1534280A1 Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol
06/01/2005EP1534279A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
06/01/2005EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
06/01/2005EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
06/01/2005EP1534273A2 Modulators of the glucocorticoid receptor and method
06/01/2005EP1534264A2 Compounds that modulate the activity of ptp-1b and tc-ptp
06/01/2005EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors
06/01/2005EP1268465B1 Triarylimidazole derivatives as cytokine inhibitors
06/01/2005EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
06/01/2005EP1114030B1 Pyridine ketones useful as herbicides
06/01/2005EP0991625B1 Inhibitors of factor xa with a neutral p1 specificity group
06/01/2005EP0708756B1 Substituted 2-phenylpyridines with herbicidal action
06/01/2005CN1622945A Thiazolidinedione derivatives and pharmaceutical composition comprising the same
06/01/2005CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
06/01/2005CN1622805A Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
06/01/2005CN1204137C Uracil compound and its appliance
06/01/2005CN1204121C 1, 4-substituted cyclic amine derivatives or dihydro indole derivatives and medicines containing same
05/2005
05/31/2005US6900331 Derivatives of epothilone B and D and synthesis thereof
05/31/2005US6900312 Thiazole-substituted β-lactams
05/31/2005US6900237 Sulfonamide compounds as protease inhibitors
05/31/2005US6900232 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis
05/31/2005US6900227 Benzodioxole derivatives
05/31/2005US6900220 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
05/31/2005US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
05/31/2005US6900211 CCR5 antagonists useful for treating aids
05/31/2005US6900202 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders
05/31/2005US6900196 Serine protease inhibitors
05/31/2005US6900180 Mixture of folic acid, vitamin b6 and b12 with carbohydrates, fats and proteins; infant formula; sleep disorders
05/31/2005US6899739 Hair dyes
1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 628